Comparison of treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors and other modalities

被引：0
|
作者：
Chandrasekar, Ponnambalam [1 ]
Krishnamurthy, Gokul [1 ]
Sundarajan, V. [1 ]
Potluri, Bernard [1 ]
机构：
[1] Princess Alexandra Hosp NHS Trusts, Loughton, England
来源：
JOURNAL OF ENDOUROLOGY | 2007年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [41] Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors
    LIU DefengJIANG HuiHONG KaiZHAO LianmingTANG Wenhao and MA Lulin Department of UrologyPeking University Third HospitalBeijing China
    CHINESE MEDICAL JOURNAL, 2010, (22)
  • [42] Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors
    Liu De-feng
    Jiang Hui
    Hong Kai
    Zhao Lian-ming
    Tang Wen-hao
    Ma Lu-lin
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3258 - 3261
  • [43] COUPLE SATISFACTION TO THE TREATMENT OF ERECTILE DYSFUNCTION WITH PHOSPHODIESTERASE-5 INHIBITORS
    Jiann, Bang Ping
    Huang, S. T.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 105 - 106
  • [44] Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
    Loeb, Stacy
    Folkvaljon, Yasin
    Lambe, Mats
    Robinson, David
    Garmo, Hans
    Ingvar, Christian
    Stattin, Par
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (24): : 2449 - 2455
  • [45] Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors
    Fleshner, N
    Harvey, M
    Adomat, H
    Wood, C
    Eberding, A
    Hersey, K
    Guns, E
    JOURNAL OF UROLOGY, 2005, 174 (02): : 636 - 641
  • [46] Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors
    Jacobsohn, Kenneth
    Wang, Run
    ASIAN JOURNAL OF ANDROLOGY, 2007, 9 (01) : 3 - 7
  • [47] Phosphodiesterase-5 inhibitors for male erectile dysfunction
    Sui, ZH
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1373 - 1388
  • [48] Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction
    Shabsigh, Ridwan
    Seftel, Allen D.
    Rosen, Raymond C.
    Porst, Hartmut
    Ahuja, Sanjeev
    Deeley, Michael C.
    Garcia, Carmen S.
    Giuliano, Francois
    UROLOGY, 2006, 68 (04) : 689 - 696
  • [49] CHOOSING THE 5TH TYPE PHOSPHODIESTERASE INHIBITORS FOR TREATMENT THE PATIENTS WITH ERECTILE DYSFUNCTION AND CHRONIC PROSTATITIS
    Esilevskiy, Yu. M.
    Demidko, Yu. L.
    Feyev, D. N.
    Gazimiev, M. A.
    Bezrukov, E. A.
    Butnaru, D. V.
    Bayduvaliev, A. M.
    Myannik, S. A.
    Epifanova, M. V.
    Chalyy, M. E.
    Kharchilava, R. R.
    ARCHIV EUROMEDICA, 2014, 4 (01): : 18 - 23
  • [50] An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions
    Ismail, Ezzat A.
    El-Sakka, Ahmed I.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (09) : 925 - 938
12345